In lung cancer research, studies have shown that TIM-3 expression is significantly elevated on NK cells in lung adenocarcinoma patients, and anti-TIM-3 blockade effectively restores the cytotoxic functions of these NK cells [210]. This evidence concerns the gene HAVCR2 and lung carcinoma.